Hutch News
Could gold be the key to making gene therapy for HIV and other blood disorders more accessible?
A proof-of-principle study published in Nature Materials shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. (Photos, diagram available for media use.)
Special delivery: Gold nanoparticles ship CRISPR cargo
Fred Hutch scientists used their new golden courier to edit genes tied to HIV, genetic blood disorders
Seattle mayor and melanoma survivor Jenny Durkan visits Fred Hutch
Mayor shares personal story as Hutch scientists outline the future of cancer therapy
The prized fraction of Fanconi Anemia
from the Adair lab and the Kiem lab, Clinical Research Division
Dr. Jen Adair honored for STEM workshop
Boys & Girls Clubs honors board president for middle school ‘Gene Therapist for a Day,’ leadership
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
Good News: Dr. Jen Adair speaks on gene therapy at TEDxNashville
Celebrating faculty and staff achievements
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
‘Can’t sit and wait’: Gene therapy trial aims to cure rare Fanconi anemia
At annual hematology meeting, Fred Hutch researchers updated their treatment of 11-year-old Behzad
Gene therapy goes global: Portable device could make future cancer, HIV cures affordable
<p>Portable 'gene therapy in a box' could make future cancer, HIV cures affordable in developing countries</p>
Good News at Fred Hutch
Celebrating faculty and staff achievements
‘A crack in the door’: Glimpses of hope for the future of brain cancer care
Fred Hutch researchers discuss brain tumor treatments in the works — and what’s coming next
This is when we need to 'double down' on cancer
Roundtable with U.S. Rep. Suzan DelBene, biomedical researchers highlights need for additional NIH funding